Vol. 1, Ed. 23 — Sun Sep 6: Nevada weighs cannabis tax overhaul, hemp beverage tax

A Nevada panel weighs eliminating the wholesale cannabis excise tax, raising the retail tax and taxing hemp beverages; Nebraska's Supreme Court upholds voter-approved medical cannabis laws; three firms seek DEA research authorizations. For general information only — not legal advice.

What is NRBC Compliance Brief?

The NRBC Compliance Brief is a daily two-minute audio briefing on U.S. alcohol and hemp/THC regulation, covering federal agencies and all 50 states: TTB rulings and rulemaking, state alcohol authority actions, the federal hemp-ban timeline, THC-beverage rules, court decisions, taxes, tariffs, licensing, and enforcement. A new episode arrives every morning around 7 AM Eastern.

Produced by the compliance desk at New Realm Brewing Co. and narrated with AI assistance under the direction of CFO Jeremy Barnes. Strictly factual and neutral: what passed, what was signed, what a court held, and the dates that matter — with every position attributed to the person or group who took it. For general information only — not legal advice.

Want the full written brief with source links in your inbox each morning? Email [e-mail] with the subject "Subscribe - Compliance Brief"

This is the New Realm Compliance Brief, Volume One, Edition Twenty-Three, for Sunday, September Sixth. A quiet weekend for regulatory news, so today's update draws mainly on Friday's developments.

The top story: Nevada's cannabis tax structure is under formal review. A subcommittee of the state's Cannabis Advisory Commission met Friday to vote on recommendations that would eliminate Nevada's fifteen percent wholesale excise tax on marijuana, raise the ten percent excise tax on retail sales, and, notably for the beverage business, impose a new excise tax on retail consumable hemp products. Any change must remain at least revenue neutral for the state education fund, which received about one hundred eight million dollars from the two taxes in fiscal year twenty twenty-four. Recommendations are due to a legislative committee by October fifth for possible action in Nevada's twenty twenty-seven session.

In federal news, three pharmaceutical service companies, Fisher Clinical Services, Irvine Labs, and PCI Pharma Services, have applied to the Drug Enforcement Administration to import or manufacture marijuana, extracts and THC for clinical research. Federal Register notices are scheduled for September eighth, with a public comment window to follow.

Around the states: Nebraska's Supreme Court unanimously upheld the state's two voter-approved medical cannabis laws, rejecting a signature challenge brought by a former state senator; the state's Medical Cannabis Commission meets September fourteenth as licensing work continues. And Michigan's Cannabis Regulatory Agency released an updated compliance best-practices guide for licensed businesses.

On the radar: the federal ban on intoxicating hemp products takes effect December eleventh, with synthetic cannabinoids still set for November twelfth. New Mexico's cannabis trade association says it plans to refile its tracking-system challenge this week with documented damages. And possible Texas court dates on the state's total THC rules are September seventeenth and October eighth.

Full details and source links are in today's email. This update is for general information only — it is not legal advice.